THERMAL-ANALYSIS AND CALORIMETRIC METHODS IN THE CHARACTERIZATION OF POLYMORPHS AND SOLVATES

被引:321
作者
GIRON, D
机构
[1] Analytical R and D, Technical Department, Basel, Sandoz Pharma
关键词
DSC; MDSC; ODSC; POLYMORPHISM; PSEUDO-POLYMORPHISM; SOLVATE;
D O I
10.1016/0040-6031(94)01953-E
中图分类号
O414.1 [热力学];
学科分类号
摘要
The definitions and thermodynamic background for interpreting thermal analysis data are presented in this review. Most drug substances and excipients which have been reported to display polymorphism and pseudo-polymorphism are referenced. The influence of experimental parameters and substance parameters on thermoanalytical data are presented. The limits and advantages of thermal methods and combined techniques are discussed. Examples describing the use of solution calorimetry and microcalorimetry are given. Thermal methods are unique in providing knowledge of thermodynamic data, for producing modifications and for distinction between polymorphs, solvates and impurities. The methods require only a small amount of material. However, for complex polymorphic behaviour, other techniques have to be used in addition. Kinetic data can be calculated in some situations. Thermal analysis methods are generally limited to routine quantitative analysis of polymorphism. Microcalorimetric techniques are useful complements for the study of polymorphism and pseudo-polymorphism and in certain cases for quantitative determinations.
引用
收藏
页码:1 / 59
页数:59
相关论文
共 308 条
[1]  
ABDALLAH O, 1989, ACTA PHARM TECHNOL, V35, P25
[2]   POLYMORPHISM OF SPIRONOLACTONE [J].
AGAFONOV, V ;
LEGENDRE, B ;
RODIER, N ;
WOUESSIDJEWE, D ;
CENSE, JM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (02) :181-185
[3]  
AHMAD TI, 1991, ANAL PROFILES DRUG S, V20, P601
[4]   EFFECT OF MOISTURE ON CRYSTALLIZATION OF THEOPHYLLINE IN TABLETS [J].
ANDO, H ;
ISHII, M ;
KAYANO, M ;
OZAWA, H .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1992, 18 (04) :453-467
[5]   POLYMORPHISM OF SULFATHIAZOLE [J].
ANWAR, J ;
TARLING, SE ;
BARNES, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (04) :337-342
[6]   KINETICS OF PHASE-TRANSFORMATIONS IN CRYSTALS OF DRUG COMPOUNDS USING TIME-RESOLVED POWDER X-RAY-DIFFRACTION [J].
ANWAR, J ;
BARNES, P .
PHASE TRANSITIONS, 1992, 39 (1-4) :3-11
[7]  
ARAFAT JA, 1988, DRUG DEV IND PHARM, V14, P2127
[8]  
BABA K, 1990, CHEM PHARM BULL, V38, P2542
[9]  
BADWAN AA, 1991, EUR J PHARM BIOPHARM, V37, P166
[10]  
BAGCHI GD, 1992, INDIAN DRUGS, V29, P561